Why Most of India's New Hospital Beds Are Expansions, Not New Builds
India's hospital chains are adding tens of thousands of beds, and a large part of them are going into buildings that already exist. Here is why, what the real share is, and when a new build still makes sense.
Summary
- Brownfield expansion (adding beds to an existing hospital, repurposing space, or buying a working hospital) now accounts for somewhere between half and nearly two-thirds of new private hospital beds in India, depending on whose estimate you use.
- Broker research puts brownfield EBITDA break-even at 6 to 12 months against 24 to 30 months for greenfield, because the land, approvals, staff, referrals and empanelments already exist.
- Greenfield still wins in genuinely underserved cities with no asset to buy, for clinical models that need a purpose-built shell, and for brands strong enough to shorten the ramp.
Every promoter imagines the new building: the atrium, the name above the door, the equipment still in its wrapping. The operators with the best returns in Indian healthcare have largely stopped building it. They add floors to hospitals that already work, or buy hospitals that are underused and fix them.
Listed chains and large private groups plan to add about 34,000 beds by FY2029 at an investment of more than ₹40,000 crore, and a large share of those beds will go into buildings that already exist. The logic says a lot about how time, trust and capital interact in this business.
First, the 59% figure
An earlier version of this article carried a 59% figure in its headline and web address, and it needs a correction. The number that circulates is closer to the private sector's share of all hospital beds in India, which ICRA puts at 59% to 60%. It is not a measured share of new beds that are brownfield.
The estimates for that share vary with the sample and the period. A 2025 rating-agency analysis of listed hospitals put about 48% of the 16,707 beds planned over FY25 to FY27 through brownfield, with the rest greenfield or acquired. Antique Broking's June 2026 sector report puts brownfield at about 63% of incremental capacity through FY30. HDFC Securities puts Max Healthcare's own pipeline at nearly 60% brownfield. The honest summary: somewhere between half and two-thirds, and rising among the chains with the strongest balance sheets.
Brownfield is the default for India's best-capitalised chains, and the exact share matters less than why.
What the terms mean
A greenfield hospital starts on empty land. It needs the plot, the design, construction, equipment, licences, accreditation, and then a slow climb from zero patients. It is the most capital-hungry and slowest way to add a bed.
Brownfield comes in three forms: new floors, wings or beds on an operating hospital; refurbishing existing space for higher-value use; or buying a working hospital and bringing in your own brand, protocols and systems. All three share the same head start. The building, staff, patients, approvals and insurer empanelments are already there.
Why the numbers favour brownfield
How the three expansion models compare on payback
| Model | EBITDA break-even | Time to maturity | Capital at risk |
|---|---|---|---|
| Brownfield expansion or acquisition | 6 to 12 months | 1 to 2 years | Lower per bed |
| Greenfield hospital | 24 to 30 months | 4 to 5 years | Highest per bed |
| Asset-light (operate and manage) | 3 to 6 months | Short | Lowest |
Brokers covering the sector have converged on the same ranges. A brownfield bed starts earning in months. A greenfield bed can spend two to three years losing money before it reaches operating break-even, and four or five before it runs at the efficiency of a mature unit. In a business where the ramp consumes working capital every month, that gap decides returns on capital more than any tariff decision.
Why greenfield is harder than the feasibility report says
Four problems rarely show up in the project report the way they show up on the ground.
- Land. A hospital needs a large, correctly zoned plot with ambulance access. In Mumbai, Delhi or Bengaluru such plots barely exist at prices a hospital can service, and even in Tier-2 cities land adds heavily to capex before anything is built.
- Time. A 50-bed hospital takes two to three years to build and a 200-bed one four to five, with accreditation after that. From board decision to a steady patient flow can take five years or more, a long time in a market that is consolidating quickly.
- Trust. A new hospital in a new town has no patient relationships, no referring doctors and no empanelment history. None of that is on the capex sheet. It shows up as empty beds, sometimes for years.
- People. Specialists are concentrated in a handful of big cities. Recruiting a full clinical team for a Tier-2 or Tier-3 site can delay opening and limit the specialties you can offer from day one.
How it works in practice: Max in Lucknow
Max Healthcare's entry into Lucknow in December 2023 is the clearest recent example. It bought the 550-bed Sahara Hospital in Gomti Nagar at an enterprise value of ₹940 crore. The hospital was running well below its capacity, but it came with about 27 acres of land in the city, a 17-storey building, licences, insurer relationships, patients and a known name.
Max rebranded it and then committed about ₹2,500 crore to the Lucknow market, including a new greenfield hospital in the city. The order is the lesson. The acquisition bought presence and trust at once, and the new build followed once the market was proven. Building first in a city where Max had no presence would have meant years of empty beds.
The same thinking runs through the rest of its pipeline, where brownfield additions are the majority, many of them in metro hospitals that also draw international patients. Analysts expect this to protect margins while the greenfield sites ramp up.
When greenfield is the right call
Brownfield is the default, not a rule. Greenfield makes sense in three situations.
The first is a genuinely underserved city with nothing worth buying. Apollo's 400-bed project in Varanasi, reported as approved in 2025, fits: a large city with real demand for organised tertiary care and no well-located private hospital to acquire and upgrade. The choice there is between building and staying out.
The second is a clinical model that cannot be retrofitted. Quaternary programmes with specific theatre, ICU and infection-control layouts sometimes need a shell designed for them.
The third is brand. A chain whose name patients already trust can compress the ramp of a new building from five years to two, because patients and referring doctors arrive with some confidence already. An unknown promoter doing the same build gets none of that. Manipal's current plan, in which about 80% of its 2,426 planned beds are greenfield, rests on exactly this bet.
The real question is whether you enter a market with proof of demand, relationships and infrastructure, or start from zero on all three at once. Brownfield solves the first two immediately. A strong brand can solve the third over time, if the demand is real and the capital is patient.
The asset-light option
Between owning and building sits the operate-and-manage contract. The chain supplies brand, protocols and systems to someone else's hospital for a fee and a share of the upside. It is the fastest route to break-even and puts the least capital at risk, at the cost of less control and a smaller share of the profit. For a chain testing a new region, it is a cheap way to learn the market before committing capital.
What this means for owners and investors
The attractive brownfield targets are well-located standalone hospitals in Tier-1 and Tier-2 cities with land and approvals in hand but not enough brand, clinical depth or systems to fill their beds. There are thousands of them. As we argued in why most hospitals never scale past one site, many will be bought rather than grown.
- If you own an underused hospital: you have something acquirers want. The question is whether you fix yourself or sell the upside to someone who will. Either way, know your occupancy, ARPOB and cost per bed cold before any conversation.
- If you are expanding: default to adding beds where you already have referrals and staff, and make greenfield justify itself against a named brownfield alternative.
- If you are buying: the skills that matter are turnaround and integration, not construction. Price in the cost of bringing protocols, billing and people up to your standard, and run proper due diligence on receivables and scheme exposure.
The move from construction to repositioning is the defining strategic shift in Indian hospitals right now. The ₹40,000 crore now being committed will reward operators who know which kind of expansion to use, where and when. That is a strategy decision before it is a building one. SRF works on these decisions with promoters and investors in hospitals and diagnostics.
How useful was this article?
One tap. It tells us what to write more of.
About the author
SRF Capital Studio
The next one
Get what we publish next, by email.
Working notes on raising, borrowing, protecting, growing and structuring capital in India. One email a week at most, and you can leave any time.
We use your address only to send this. See our privacy policy.
We store your address to send you these emails and nothing else. See our privacy policy.
Related reading
